GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk

BACKGROUND: GlycA is a novel spectroscopic marker of systemic inflammation with low intra-individual variability and other attributes favoring its clinical use in patients with chronic inflammatory and autoimmune diseases. GlycA is unique in its composite nature, reflecting both increased glycan com...

Descripción completa

Detalles Bibliográficos
Autores principales: Connelly, Margery A., Otvos, James D., Shalaurova, Irina, Playford, Martin P., Mehta, Nehal N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658936/
https://www.ncbi.nlm.nih.gov/pubmed/29078787
http://dx.doi.org/10.1186/s12967-017-1321-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658936/
https://www.ncbi.nlm.nih.gov/pubmed/29078787
http://dx.doi.org/10.1186/s12967-017-1321-6

Ejemplares similares